|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.597
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.500
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.471
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.466
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.456
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.410
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.370
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.361
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.324
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.316
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.307
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.302
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.293
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.290
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.279
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.275
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.274
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.259
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.250
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.243
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.238
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.229
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.223
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.214
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.214
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.213
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.213
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.209
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.207
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.203
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.199
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.197
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.196
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.196
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.195
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.195
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.186
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.176
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.173
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.173
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.172
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.170
|
|
|
|
purkinje myocyte differentiation
|
GO:0003168 |
1 |
0.170
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.170
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.169
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.168
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.166
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.165
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.165
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.163
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.162
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.161
|
|
|
|
atrioventricular node cell development
|
GO:0060928 |
2 |
0.157
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.155
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.154
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.152
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.151
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.150
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.149
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.149
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.148
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.147
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.145
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.145
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.143
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.143
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.143
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.142
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.142
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.142
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.141
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.140
|
|
|
|
ventral spinal cord interneuron fate determination
|
GO:0060580 |
1 |
0.139
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.139
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.138
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.137
|
|
|
|
menarche
|
GO:0042696 |
1 |
0.135
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.132
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.130
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.129
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.127
|
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.127
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.126
|
|
|
|
cardiac pacemaker cell fate commitment
|
GO:0060927 |
1 |
0.126
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.125
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.124
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.122
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.119
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.119
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.116
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.116
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.113
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.113
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.111
|
|
|
|
atrioventricular node cell fate commitment
|
GO:0060929 |
1 |
0.110
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
25 |
0.109
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.109
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.108
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.108
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.107
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.106
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.106
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.105
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.105
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.103
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.103
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.102
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.101
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.100
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.100
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.099
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.096
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.096
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.095
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.095
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.094
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.094
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.093
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.093
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.093
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.092
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.092
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.091
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.090
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.090
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.090
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.090
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.090
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.089
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.089
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.089
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.088
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.088
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.088
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.087
|
|
|
|
atrioventricular node cell differentiation
|
GO:0060922 |
2 |
0.086
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.086
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.085
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.084
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.084
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.083
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.083
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.082
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.081
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.081
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.080
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.079
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.078
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.078
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.077
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.075
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.075
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.075
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.075
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.074
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.074
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.074
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.074
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.073
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.072
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.072
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.072
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.071
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.071
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.071
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.070
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.070
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.070
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.070
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.070
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.070
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.069
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.069
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.069
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.068
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.067
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.067
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.066
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.066
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.065
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.065
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.064
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.064
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.063
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.062
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.062
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.062
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.062
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.062
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.062
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.061
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.061
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.060
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.060
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.060
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.060
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.059
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.059
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.059
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.059
|
|
|
|
type b pancreatic cell fate commitment
|
GO:0003327 |
1 |
0.059
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.058
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.058
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.058
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.058
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.058
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.058
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.057
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.057
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.057
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.057
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.057
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.056
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.056
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.056
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.056
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.056
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.056
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.056
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.055
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.055
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.054
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.054
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.054
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.054
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.054
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.054
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.054
|
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.053
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.053
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.052
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.052
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.052
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.052
|
|
|
|
pulmonary myocardium development
|
GO:0003350 |
3 |
0.051
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.051
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.051
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.050
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.050
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.050
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.050
|
|
|
|
cerebral cortex tangential migration using cell axon interactions
|
GO:0021824 |
3 |
0.050
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.049
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.049
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.049
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.049
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.049
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.048
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.048
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.048
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.048
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.048
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.048
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.047
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.047
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.047
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.047
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.047
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.047
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.047
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.047
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.047
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.046
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.046
|
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
38 |
0.046
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.046
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.046
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.046
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.045
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.045
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.045
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.045
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
23 |
0.045
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.044
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.044
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.044
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.044
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.043
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.043
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.043
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.043
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.043
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.042
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.042
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.042
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.042
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.042
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.041
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.041
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.041
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.041
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.041
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.041
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.041
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.041
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.041
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.041
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.041
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.040
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.040
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.040
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.040
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.040
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.040
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.040
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.039
|
|
|
|
septum transversum development
|
GO:0003343 |
2 |
0.039
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.039
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.039
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.039
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.039
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.038
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.038
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.038
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.038
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.038
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.038
|
|
|
|
globus pallidus development
|
GO:0021759 |
2 |
0.038
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.038
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.038
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.038
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.037
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.037
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.037
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.037
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.037
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.037
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.037
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.037
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.037
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.037
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.037
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.037
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.037
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.037
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.037
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.037
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.037
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.037
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.036
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.036
|
|
|
|
t helper 2 cell cytokine production
|
GO:0035745 |
4 |
0.036
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.036
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.036
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.036
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.036
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.036
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.036
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.036
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.036
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.036
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.036
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.036
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.036
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.036
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.036
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.035
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.035
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.035
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.035
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.035
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.035
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.035
|
|
|
|
heart induction
|
GO:0003129 |
2 |
0.035
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.035
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.035
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.035
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.035
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.034
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
26 |
0.034
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.034
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.034
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.034
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.033
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.033
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.033
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.033
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.033
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.033
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.033
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.032
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.032
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.032
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.032
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.032
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.032
|
Mouse |
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.032
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.031
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.031
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.031
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.031
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.031
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.031
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.031
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.031
|
|
|
|
regulation of endodermal cell fate specification
|
GO:0042663 |
2 |
0.031
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.031
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.031
|
|
|
|
negative regulation of interleukin 5 secretion
|
GO:2000663 |
1 |
0.031
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.030
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.030
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.030
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.030
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.030
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.030
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.030
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.030
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.030
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.030
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.030
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.030
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.030
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.030
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.030
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.030
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.030
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.030
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.030
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.030
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.030
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.029
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.029
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.029
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.029
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.029
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.029
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.029
|
Mouse |
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.029
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.029
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.029
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.029
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.029
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.029
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.029
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.029
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.029
|
|
|
|
innate immune response in mucosa
|
GO:0002227 |
3 |
0.029
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.029
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.029
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.028
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.028
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.028
|
|
|
|
defense response to gram negative bacterium
|
GO:0050829 |
28 |
0.028
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.028
|
|
|
|
hypothalamus cell differentiation
|
GO:0021979 |
8 |
0.028
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.028
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.028
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.028
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.028
|
|
|
|
purkinje myocyte development
|
GO:0003165 |
1 |
0.028
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.028
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.028
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.028
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.028
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.028
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
21 |
0.028
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.028
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.028
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.028
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.028
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.028
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.027
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.027
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.027
|
|
|
|
negative regulation of interleukin 13 secretion
|
GO:2000666 |
1 |
0.027
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.027
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.027
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.027
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.027
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.027
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.027
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.027
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.027
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.027
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.027
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.026
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.026
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.026
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.026
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.026
|
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.026
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.026
|
|
|
|
muscle cell apoptotic process
|
GO:0010657 |
18 |
0.026
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.026
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.026
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.026
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.026
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.026
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.025
|
|
|
|
regulation of digestive system process
|
GO:0044058 |
13 |
0.025
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.025
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.025
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.025
|
|
